Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
37

REGN
Regeneron Pharmaceuticals

Last Price:
829.32
Seasonality Move:
11.8%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Regeneron Pharmaceuticals Price Quote

$829.32
-0.11 (0.05%)
(Updated: November 6, 2024 at 4:00 AM ET)

Regeneron Pharmaceuticals Key Stats

Sell
37
Regeneron Pharmaceuticals (REGN) is a Sell

Day range:
$819.14 - $836.63
52-week range:
$783.57 - $1,211.20
Dividend yield:
0%
P/E ratio:
23.85
P/S ratio:
6.89
P/B ratio:
3.11%

Volume:
620.7K
Avg. volume:
762K
1-year change:
1.53%
Market cap:
$91.1B
Revenue:
$13.1B
EPS:
$40.41

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.2B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.5B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.9B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 16.02%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 13.44%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 17.19%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 29.81% 6.38%
Revenue: 10.65% 1.47%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 1,095.43
Upside from Last Price: 32.07%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    173.2M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2.1M REGN shares are owned by insiders